Search results
Results from the WOW.Com Content Network
Transmission-based precautions are infection-control precautions in health care, in addition to the so-called "standard precautions". They are the latest routine infection prevention and control practices applied for patients who are known or suspected to be infected or colonized with infectious agents, including certain epidemiologically important pathogens, which require additional control ...
[3] [5] [12] [13] [14] Other names include morbilli, rubeola, red measles, and English measles. [1] [2] Both rubella, also known as German measles, and roseola are different diseases caused by unrelated viruses. [15] Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days.
The name rubella is sometimes confused with rubeola, an alternative name for measles in English-speaking countries; the diseases are unrelated. [ 63 ] [ 64 ] In some other European languages, like Spanish , rubella and rubeola are synonyms, and rubeola is not an alternative name for measles.
Droplet precautions are intended to prevent transmission of pathogens spread through close respiratory or mucous membrane contact with respiratory secretions. Preventative measures such as personal protective equipment can be worn to prevent direct contact with mucous membrane and respiratory secretion.
The virus causes measles, a highly contagious disease transmitted by respiratory aerosols that triggers a temporary but severe immunosuppression.Symptoms include fever, cough, runny nose, inflamed eyes and a generalized, maculopapular, erythematous rash and a pathognomonic Koplik spot seen on buccal mucosa opposite to lower 1st and 2nd molars.
The 1962–1965 rubella epidemic was an outbreak of rubella across Europe and the United States. [1] [2] The Rubella virus, also known as the German measles, is a single-stranded RNA virus from the family Togaviridae and genus Rubivirus. [3]
Rubella virus (RuV) is the pathogenic agent of the disease rubella, transmitted only between humans via the respiratory route, and is the main cause of congenital rubella syndrome when infection occurs during the first weeks of pregnancy.
This is an accepted version of this page This is the latest accepted revision, reviewed on 20 December 2024. Combined vaccine against measles, mumps, and rubella Pharmaceutical compound MMR vaccine MMR vaccine Combination of Measles vaccine Vaccine Mumps vaccine Vaccine Rubella vaccine Vaccine Clinical data Trade names M-M-R II, Priorix, Tresivac, others Other names MPR vaccine AHFS / Drugs ...